HuGE Literature Finder
Records
1
-
2
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Sep 31 (27): 3327-34. Sequist Lecia V, Yang James Chih-Hsin, Yamamoto Nobuyuki, O'Byrne Kenneth, Hirsh Vera, Mok Tony, Geater Sarayut Lucien, Orlov Sergey, Tsai Chun-Ming, Boyer Michael, Su Wu-Chou, Bennouna Jaafar, Kato Terufumi, Gorbunova Vera, Lee Ki Hyeong, Shah Riyaz, Massey Dan, Zazulina Victoria, Shahidi Mehdi, Schuler Mart |
Southwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011 Dec 22 (12): 2610-5. Iqbal S, Goldman B, Fenoglio-Preiser C M, Lenz H J, Zhang W, Danenberg K D, Shibata S I, Blanke C |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jul 06, 2022
- Content source: